Clinical Trial Update: A Trial of Thymalfasin in Adult Patients With Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating thymalfasin in adults with hepatocellular carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Thymalfasin (thymosin alpha-1)

Snippet

Sponsor: SciClone Pharmaceuticals | Conditions: Carcinoma, Hepatocellular | Phase 2 | Status: COMPLETED